Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.

Yang FQ, Yu YY, Wang GQ, Chen J, Li JH, Li YQ, Rao GR, Mo GY, Luo XR, Chen GM.

J Viral Hepat. 2012 Aug;19(8):581-93. doi: 10.1111/j.1365-2893.2012.01589.x. Epub 2012 Feb 26.

PMID:
22762143
2.

Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.

Yang SH, Lee CG, Park SH, Im SJ, Kim YM, Son JM, Wang JS, Yoon SK, Song MK, Ambrozaitis A, Kharchenko N, Yun YD, Kim CM, Kim CY, Lee SH, Kim BM, Kim WB, Sung YC.

Gene Ther. 2006 Jul;13(14):1110-7. Epub 2006 Mar 9.

PMID:
16525482
3.

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.

Am J Gastroenterol. 2005 Nov;100(11):2463-71.

PMID:
16279901
4.
5.

In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.

Horiike N, Fazle Akbar SM, Michitaka K, Joukou K, Yamamoto K, Kojima N, Hiasa Y, Abe M, Onji M.

J Clin Virol. 2005 Feb;32(2):156-61.

PMID:
15653419
6.

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Bréchot C, Michel ML.

Hepatology. 2004 Oct;40(4):874-82.

PMID:
15382173
7.

Efficacy of pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection.

Senturk H, Tabak F, Ozaras R, Erdem L, Canbakan B, Mert A, Yurdakul I.

Dig Dis Sci. 2009 Sep;54(9):2026-30. doi: 10.1007/s10620-008-0586-2. Epub 2008 Nov 19.

PMID:
19016327
8.

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.

Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN; Asia Hepatitis Lamivudine Study Group..

Hepatology. 2001 Jun;33(6):1527-32.

PMID:
11391543
9.

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Bréchot C, Pol S, Michel ML.

Vaccine. 2006 May 22;24(21):4482-9. Epub 2005 Aug 18.

PMID:
16310901
10.

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF.

J Med Virol. 2002 Apr;66(4):452-60.

PMID:
11857521
11.

Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.

Sarin SK, Sandhu BS, Sharma BC, Jain M, Singh J, Malhotra V.

J Viral Hepat. 2004 Nov;11(6):552-8.

PMID:
15500556
12.

Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.

Sokal EM, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR, Gardener SD, Jonas MM.

Hepatology. 2006 Feb;43(2):225-32.

PMID:
16440364
13.

An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.

Yao G, Cui Z, Wang B, Yao J, Zeng M.

Chin Med J (Engl). 2002 Dec;115(12):1814-8.

PMID:
12622930
14.

[Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].

Deng H, Zhao ZX, Xu QH, Zhou YP, Chen YM, Yao JL.

Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):305-8. Chinese.

PMID:
12773249
15.

A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.

Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.

Hepatobiliary Pancreat Dis Int. 2004 May;3(2):188-93.

17.

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study.

Santantonio T, Niro GA, Sinisi E, Leandro G, Insalata M, Guastadisegni A, Facciorusso D, Gravinese E, Andriulli A, Pastore G.

J Hepatol. 2002 Jun;36(6):799-804.

PMID:
12044531
18.
19.

Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.

Dikici B, Bosnak M, Ucmak H, Dagli A, Ece A, Haspolat K.

J Gastroenterol Hepatol. 2003 Feb;18(2):218-22.

PMID:
12542609
20.

Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis.

Oh JM, Kyun J, Cho SW.

Pharmacotherapy. 2002 Oct;22(10):1226-34.

PMID:
12389873

Supplemental Content

Support Center